Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting

Xianglei Fu1, Yanbin Shi2, Tongtong Qi1

  • 1Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.

Insights

Precise cancer nanomedicine requires delivering drugs to subcellular targets. This review explores nanoformulation strategies to enhance anticancer drug delivery and efficacy for improved patient outcomes.

Area of Science:

  • Nanomedicine
  • Cancer Therapeutics
  • Subcellular Targeting

Background:

  • Effective cancer therapy depends on drug delivery to subcellular targets.
  • Carcinogenesis involves key biological macromolecules at the subcellular level.
  • Current strategies often lack precision in subcellular drug distribution.

Purpose of the Study:

  • To review recent construction strategies and release patterns of cancer cell subcellular-targeting nanoformulations.
  • To provide guidance for designing precise nanomedicine.
  • To highlight future challenges and perspectives in the field.

Main Methods:

  • Review of recent literature on nanoformulation design for subcellular targeting.
  • Analysis of drug release mechanisms and targeting efficiencies.
  • Discussion of construction strategies for targeted nanomedicine.

Main Results:

  • Various nanoformulations demonstrate potential for subcellular targeting in cancer cells.
  • Specific design strategies can improve drug accumulation at intracellular targets.
  • Controlled release patterns are crucial for sustained therapeutic effects.

Conclusions:

  • Subcellular targeting of nanoformulations is critical for enhancing anticancer efficacy.
  • Further research into nanoformulation design and release kinetics is needed.
  • Advancing precise nanomedicine requires addressing translational challenges.